| GA23164-250mg |
|
41961-56-2 |
Macrophage Inhibitory Peptide
|
0 |
C15H28N4O5 |
|
|
|
| GA23164-50mg |
|
41961-56-2 |
Macrophage Inhibitory Peptide
|
0 |
C15H28N4O5 |
|
|
|
| GA23163-1mg |
|
1872440-65-7 |
|
0 |
C205H326N64O61S5 |
|
|
|
| GA23163-005mg |
|
1872440-65-7 |
|
0 |
C205H326N64O61S5 |
|
|
|
| GA23162-5g |
|
13673-95-5 |
L-β-Phenyllactic acid-OMe
|
0 |
C10H12O3 |
|
|
|
| GA23162-1g |
|
13673-95-5 |
L-β-Phenyllactic acid-OMe
|
0 |
C10H12O3 |
|
|
|
| GA23161-1mg |
|
2022974-40-7 |
Lys-Trp-Lys-(Ser(GlcNAc-β-D)⁴⁰⁰)-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide
|
0 |
C164H263N47O47S |
|
|
|
| GA23161-005mg |
|
2022974-40-7 |
Lys-Trp-Lys-(Ser(GlcNAc-β-D)⁴⁰⁰)-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide
|
0 |
C164H263N47O47S |
|
|
|
| GA23160-5mg |
|
172615-51-9 |
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human)
|
0 |
C73H114N18O22 |
|
|
|
| GA23160-1mg |
|
172615-51-9 |
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human)
|
0 |
C73H114N18O22 |
|
|
|
| GA23159-250mg |
|
4418-81-9 |
Lysinoalanine . 2 HCl (diastereomeric mixture: LL + LD)
|
0 |
C9H19N3O4 · 2 HCl |
|
|
|
| GA23159-50mg |
|
4418-81-9 |
Lysinoalanine . 2 HCl (diastereomeric mixture: LL + LD)
|
0 |
C9H19N3O4 · 2 HCl |
|
|
|
| GA23158-100mg |
|
71800-37-8 |
Lys-(Des-Arg⁹,Leu⁸)-Bradykinin
|
0 |
C47H75N13O11 |
|
|
|
| GA23158-25mg |
|
71800-37-8 |
Lys-(Des-Arg⁹,Leu⁸)-Bradykinin
|
0 |
C47H75N13O11 |
|
|
|
| GA23157-100mg |
|
103545-18-2 |
|
0 |
C54H83N17O12 |
|
|
|
| GA23157-25mg |
|
103545-18-2 |
|
0 |
C54H83N17O12 |
|
|
|
| GA23156-5mg |
|
292141-31-2 |
Luteinizing Hormone-Releasing Hormone Antagonist
|
0 |
C48H59ClN12O8 |
|
|
|
| GA23156-1mg |
|
292141-31-2 |
Luteinizing Hormone-Releasing Hormone Antagonist
|
0 |
C48H59ClN12O8 |
|
|
|
| GA23155-5g |
|
1596-67-4 |
|
0 |
C15H15NO4 |
|
|
|
| GA23155-1g |
|
1596-67-4 |
|
0 |
C15H15NO4 |
|
|
|
